The Institute for Nuclear Medicine performs scanning examinations using radioactive dyes that enable imaging of disease processes. For most examinations, the radioactive dye is injected intravenously and a special screening camera, sensitive to gamma rays, identifies and records radioactive emission from the body. The medical equipment of the institute consists of advanced cameras that are constantly being revised and updated with the latest technology.
The institute performs the following examinations:
- Tumor Scanning: Gallium scanning to diagnose and follow-up on patients with lymphoma, scans using fluoro-deoxi-glucose (FDG) for head and neck tumors, lung tumors, lymphoma, breast tumors, tumors of the digestive tract, skeletal tumors, identifying sources of high levels of anti-CEA, melanoma, thyroid cancer using iodine 131, MIBG scans, somatostatin and DMSA panteolanti in neuro-endocrine tumors.
- In January 2002 the institute added to its arsenal the modern PET/CT that enables simultaneous imaging of tumors using both nuclear medicine and CT technology all in one modern machine.
- Scanning sites of infection: scanning tagged leukocytes to identify infections in joint prostheses, at fracture sites and post-surgical sites, diagnosing and examining active inflammatory processes in the intestines.
- Heart scans to assess coronary artery disease, cardiac muscle viability and cardiac function.
- Digestive system scans: esophageal peristalsis, reflux, and gastric emptying.
- Urology assessment: assessment of renal draining using Fusid (Lasix,) assessment scan of renal-vascular hypertension using Capoten and quantitative SPECT with Tc-DMSA to assess functional renal reserve.
- Brain scan: clarification of transient ischemic attacks (TIA) or cerebral vascular accidents (CVA,) dementia, post-traumatic conditions, identification of epileptic foci, and assessment of brain tumors after treatment.
- Endocrinology: diseases of the thyroid and parathyroid.